Advertisement

European Archives of Oto-Rhino-Laryngology

, Volume 248, Issue 8, pp 459–464 | Cite as

Inhibition of adenylate-cyclase-coupled G protein complex by ototoxic diuretics andcis-platinum in the inner ear of the guinea pig

  • T. Koch
  • B. Gloddek
Article

Summary

The enzyme adenylate cyclase produces the second messenger cAMP and is located in the mammalian inner ear, predominantly in the stria vascularis and to a lesser extent in the organ of Corti. It is coupled to hormone receptors and regulating G proteins in the outer cell membrane. By means of immunofluorescence in cryostat sections of the guinea pig cochlea, we could demonstrate the G proteins GS and Gi, which belong to the adenylate cyclase complex. These proteins had their highest density in the stria vascularis. In membrane preparations of this tissue, the adenylate cyclase complex was inhibited by ototoxic drugs (furosemide, ethacrynic acid and cis-platinum). Stimulation at different sites of the enzyme system showed that the target of these drugs was probably the regulating G protein complex and not the enzyme molecule itself. Inhibition depended on the concentration of the drug and the incubation time.

Key words

Stria vascularis cAMP G proteins Hormones Ototoxic drugs 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ahlström P, Thalmann I, Thalmann R, Ise I (1974) Cyclic AMP and adenylate cyclase in the inner ear. Laryngoscope 85:1241–1258Google Scholar
  2. 2.
    Anniko M, Sobin A (1986) Cisplatin: evaluation of its ototoxic potential. Am J Otolaryngol 7:276–293Google Scholar
  3. 3.
    Bagger-Sjöbäck D, Filipek CS, Schacht J (1980) Characteristics and drug responses of cochlear and vestibular adenylate cyclase. Arch Otorhinolaryngol 228:217–222Google Scholar
  4. 4.
    Bosher SK, Smith C, Warren RL (1973) The effects of ethacrynic acid upon the cochlear endolymph and stria vascularis. Acta Otolaryngol (Stockh) 75:184–191Google Scholar
  5. 5.
    Brusilow SW (1975) Propranolol antagonism to the effect of furosemide on the composition of endolymph in guinea pigs. Can J Physiol Pharmacol 54:42–48Google Scholar
  6. 6.
    Cohn ES, Gordes EH, Brusilow SW (1970) Ethacrynic acid effect on the composition of cochlear fluids. Science 171:910–911Google Scholar
  7. 7.
    Comis SD, Osborne MP, Jeffries DJR (1990) Effect of furosemide upon morphology of hair bundles in guinea pig cochlear hair cells. Acta Otolaryngol (Stockh) 109:49–56Google Scholar
  8. 8.
    Forge A, Brown NM (1982) Ultrastructural and electrophysiological studies of acute ototoxic effects of furosemide. Br J Audiol 16:109–116Google Scholar
  9. 9.
    Hayashida T, Hiel H, Dulon D, Erre JP, Guilhame A, Aran JM (1989) Dynamic changes following combined treatment with gentamicin and ethacrynic acid with and without acoustic stimulation. Acta Otolaryngol (Stockh) 108:404–413Google Scholar
  10. 10.
    Helmreich EJM, Pfeuffer T (1985) Regulation of signal transduction by β-adrenergic hormone receptors. Trends Pharmacol Sci 6:438–443Google Scholar
  11. 11.
    Hoeve LJ, Mertens zur Borg IRAM, Rodenburg M, Brocaar MP, Groen BGS (1988) Correlations between cis-platinum dosage and toxicity in a guinea pig model. Arch Otorhinolaryngol 245:98–102Google Scholar
  12. 12.
    Koch T, Zenner HP (1988) Adenylate cyclase and G proteins as a signal transfer system in the guinea pig inner ear. Arch Otorhinolaryngol 245:82–97Google Scholar
  13. 13.
    Koch T, Lehnhardt E, Böttinger H, Pfeuffer T, Palm D, Fischer B, Radeke H, Hesch RD (1990) Sensorineural hearing loss owing to deficient G proteins in patients with pseudohypoparathyroidism: results of a multicentre study. Eur J Clin Invest 20:416–421Google Scholar
  14. 14.
    Kusakari J, Ise I, Comegys TH, Thalmann I, Thalmann R (1978) Effect of ethacrynic acid, furosemide and ouabain upon the endolymphatic potential and upon high energy phosphates of the stria vascularis. Laryngoscope 88:12–37Google Scholar
  15. 15.
    Laurell G, Engström B (1989) The combined effect of cisplatin and furosemide on hearing function in guinea pigs. Hear Res 38:19–26Google Scholar
  16. 16.
    Laurell G, Engström B (1989) The ototoxic effect of cisplatin on guinea pigs in relation to dosage. Hear Res 38:27–34Google Scholar
  17. 17.
    Mees K, Herzog V, Maurer I (1989) Hormonrezeptoren im Innenohr. Laryngol Rhinol Otol 68:225–230Google Scholar
  18. 18.
    Melichar I, Syka J (1978) The effects of ethacrynic acid upon the potassium concentration in guinea pig cochlear fluids. Hear Res 1:35–41Google Scholar
  19. 19.
    Mori N, Shugyo A, Asai H (1989) The effects of argininevasopressin and its analogues upon the endocochlear potential in the guinea pig. Acta Otolaryngol (Stockh) 107:80–84Google Scholar
  20. 20.
    Nakai Y (1971) Electron microscopic study of the inner ear after ethacrynic acid intoxication. Pract Otorhinolaryngol 33: 366–376Google Scholar
  21. 21.
    Paloheimo S, Thalmann R (1977) Influence of “loop” diuretics upon Na-K-ATPase and adenylate cyclase of the stria vascularis. Arch Otorhinolaryngol 217:347–359Google Scholar
  22. 22.
    Pike DA, Bosher SK (1980) The time course of the strial changes produced by intravenous furosemide. Hear Res 3:79–89Google Scholar
  23. 23.
    Quick CA, Hoppe W (1975) Permanent deafness associated with furosemide administration. Ann Otol 84:94–101Google Scholar
  24. 24.
    Schacht J (1982) Adenylate cyclase and cochlear fluid balance. Am J Otolaryngol 3:328–331Google Scholar
  25. 25.
    Schacht J (1985) Hormonal regulation of adenylate cyclase in the stria vascularis of the mouse. Hear Res 20:9–13Google Scholar
  26. 26.
    Schaefer SD, Post JD, Close LG, Wright CG (1985) Ototoxicity of low- and moderate-dose cisplatin. Cancer 56:1934–1939Google Scholar
  27. 27.
    Schröder M, Laskawi R, Stennert E, Kühnle H, Thiele FW (1986) Cis-Platin Ototoxizität — eine klinische Studie. Laryngol Rhinol Orel 65:86–89Google Scholar
  28. 28.
    Seamon KB, Padgett W, Daly JW (1981) Forskolin: unique diterpene activator of adenylate cyclase in membranes and intact cells. Proc Natl Acad Sci USA 78:3363–3367Google Scholar
  29. 29.
    Spiegel AM, Gierschik P, Levine MA, Downs RW (1985) Clinical implications of guanine nucleotide-binding proteins as receptor-effector couplers. N Engl J Med 312:26–33Google Scholar
  30. 30.
    Tange RA, Vuzevski VD (1984) Changes in the stria vascularis of the guinea pig due to cis-platinum. Arch Otorhinolaryngol 239:41–47Google Scholar
  31. 31.
    Thalmann R, Ise I, Bohne BA, Thalmann I (1977) Actions of “loop” diuretics and mercurials upon the cochlea. Acta Otolaryngol (Stockh) 83:221–232Google Scholar
  32. 32.
    Thalmann I, Kobayashi T, Thalmann R (1982) Arguments against a mediating role of the adenylate cyclase — cyclic AMP system in the ototoxic action of loop diuretics. Laryngoscope 92:589–593Google Scholar
  33. 33.
    Zajie G, Anniko M, Schacht J (1983) Cellular localization of adenylate cyclase in the developing and mature inner ear of the mouse. Hear Res 10:249–261Google Scholar
  34. 34.
    Zenner HP, Zenner B (1979) Vasopressin and isoproterenol activate adenylate cyclase in the guinea pig inner ear. Arch Otorhinolaryngol 222:275–283Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • T. Koch
    • 1
  • B. Gloddek
    • 1
  1. 1.Department of Otorhinolaryngology, Medizinische HochschuleUniversity of HannoverHannoverGermany

Personalised recommendations